Blueclinical Investigacao E Desenvolvimento Em Saude Lda.
- Address
- Hospital Da Prelada 0 Floor And 3 rd Floor, Rua Sarmento De Beires 153, 4250-449 Porto, Portugal
Diseases of the Nervous System and Healthy Volunteer Research
The Blueclinical Investigacao E Desenvolvimento Em Saude Lda. site in Porto is active in nervous system diseases research, with multiple sclerosis appearing among the main conditions of interest. Much of the work also involves healthy participants, supporting studies that help compare treatments, assess absorption, and better understand how medicines behave in the body.
- Research related to multiple sclerosis and other nervous system diseases
- Studies in healthy participants to support treatment comparison and medicine evaluation
- Clinical work focused on understanding how therapies perform and are tolerated
This area reflects a broad effort to improve neurology-related care while also generating evidence that supports the development of new and existing medicines.
Bacterial Infections, Mycoses, and Anti-Infective Research
Another key focus at this pharmaceutical company site is bacterial infections and mycoses, including studies connected to amoxicillin and clavulanic acid. The trials in this area are designed to compare medicines and evaluate how well established treatments can be matched or improved for future use.
- Trials involving anti-infective medicines used for common infections
- Research on amoxicillin and clavulanic acid formulations
- Work aimed at assessing treatment consistency and product performance
These studies help strengthen evidence for infection treatment options and support the development of reliable therapies for everyday clinical use.
Metabolic, Cardiovascular, and General Medicine Studies
Blueclinical also conducts a large volume of research in metabolic and cardiovascular care, alongside broader studies that cannot be tied to one specific disease area. Conditions and treatments under investigation include diabetes-related medicines, blood clot prevention, and therapies linked to vascular hyperpermeability in sepsis and septic shock.
- Studies of medicines for diabetes and related metabolic conditions
- Research on cardiovascular treatments, including clot-related therapies
- Clinical evaluation of therapies for sepsis and septic shock
The research here is mainly focused on comparing formulations, checking treatment effectiveness, and supporting the safe use of widely relevant medicines across several therapeutic areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 13 of 14 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Laboratorios Leon Farma S.A.1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +13 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 84 other sites in Portugal
Therapeutic Area Benchmark — Portugal
Select a therapeutic area to compare against other sites in Portugal.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Portugal
Market Share
Country: Portugal
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Blueclinical Investigacao E Desenvolvimento Em Saude Lda.
lock Showing 1 of 87 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Bioequivalence and Bioavailability Study of Indapamide SR 1.5 mg Mini-Tablets versus Indapamide SR 1.5 mg and Indapamide IR 2.5 mg Tablets in Healthy Participants Under Fasting Conditions | Institut De Recherches Internationales Servier IRIS | Phase I | Not Recruiting | Apr 2026 | Jul 2026 |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cytisinicline | 3 | Unknown | 2022-10-17 | 2023-08-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.